• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About NSF
    • About the Conference
    • Project Team
    • Advisory Board
  • Conference
  • Abstracts
    • Abstract Submission Process
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • 2023 ERN Recap Video
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Pseudo Short Aptamer: Targeting to Cancer Telomerase

Undergraduate #179
Discipline: Chemistry and Chemical Sciences
Subcategory: Cancer Research
Session: 4
Room: Exhibit Hall A

Jessie Cook - Fayetteville State University
Co-Author(s): Dr. Hennguang Li, Fayetteville State University; Fayetteville, NC, 28301



Pseudo aptamers are the derivatives of an aptamer, known as “chemical antibodies”. Although research is being continually conducted, there are multiple concerns that come with the applications of aptamers referring to their degradation, excretion and stability. This leads us to finding a way to optimize aptamers by structural modifications to ensure they can target the defined molecules efficiently. The goal of this research is to build a series of pseudo aptamers that target the telomerases of cancer cells based on rational design. In addition, simplifying the longer chain of the oligomer over the conventional length will bring more benefits of the actual applications in the manners of activity, toxicity, delivery ability, metabolizing, and feasible fabrications. In our research we had tested derivatives of anti-HIV reagents, a conjugated pseudo nucleoside against four lung cancer cells. All cancer cells were apoptosis in the range of IC50 56μM – 68μM. Telomerase is a kind of retro transcriptase, this result suggests, the mechanism would be similar to the inhibition of retro transcriptase in the HIV virus. By developing a solution phase synthesis, we are able to create an intensive helix designed triazole, and sulfonyl linked pseudo short aptamer that is intended to be structurally sound, appropriate to target the cancer telomerase, and either deactivate their rate of growth or make them reach cessation.

Funder Acknowledgement(s): Strengthening Student Success in STEM; Ronald E. McNair Program; Cancer Institute, Sichuan Cancer Hospital, Chengdu, Sichuan, China, 610041

Faculty Advisor: Dr. Hengguang Li, hli@uncfsu.edu

Role: My role in this research was to create the Zidovudine:Lithocholic Acid conjugate. I was responsible for making sure that the conjugate was pure and tested via multiple methods.

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science